Matrix Capital Management Company

Latest statistics and disclosures from Matrix Capital Management Company's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are MAZE, AURA, ZNTL, and represent 100.00% of Matrix Capital Management Company's stock portfolio.
  • Reduced shares in these 2 stocks: GFS (-$133M), MAZE (-$22M).
  • Sold out of its position in GFS.
  • Matrix Capital Management Company was a net seller of stock by $-154M.
  • Matrix Capital Management Company has $107M in assets under management (AUM), dropping by -52.09%.
  • Central Index Key (CIK): 0001410830

Tip: Access up to 7 years of quarterly data

Positions held by Matrix Capital Management Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Matrix Capital Management Company

Matrix Capital Management Company holds 3 positions in its portfolio as reported in the September 2025 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Maze Therapeatics (MAZE) 40.2 $43M -33% 1.7M 25.93
 View chart
Aura Biosciences (AURA) 40.1 $43M 6.9M 6.18
 View chart
Zentalis Pharmaceuticals (ZNTL) 19.7 $21M 14M 1.51
 View chart

Past Filings by Matrix Capital Management Company

SEC 13F filings are viewable for Matrix Capital Management Company going back to 2010

View all past filings